用于西班牙流感的血液制品：未来能否用于治疗H5N1？ - Suppr

Suppr

超能文献

Blood products for Spanish influenza: a future H5N1 treatment?

作者信息

Logtenberg Susan J, Bilo Henk J

出版信息

Ann Intern Med. 2007 May 1;146(9):686-7; author reply 687. doi: 10.7326/0003-4819-146-9-200705010-00020.

DOI:10.7326/0003-4819-146-9-200705010-00020

PMID:17470841

Abstract

摘要

相似文献

Blood products for Spanish influenza: a future H5N1 treatment?

Ann Intern Med. 2007 May 1;146(9):686-7; author reply 687. doi: 10.7326/0003-4819-146-9-200705010-00020.

Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?

Ann Intern Med. 2006 Oct 17;145(8):599-609. doi: 10.7326/0003-4819-145-8-200610170-00139. Epub 2006 Aug 29.

Avian influenza: exploring all the avenues.

Ann Intern Med. 2006 Oct 17;145(8):631-2. doi: 10.7326/0003-4819-145-8-200610170-00140. Epub 2006 Aug 29.

Immunology. Flu antibodies stir new hope for treatment, vaccine.

Science. 2009 Feb 27;323(5918):1160. doi: 10.1126/science.323.5918.1160.

Treatment with convalescent plasma for influenza A (H5N1) infection.

N Engl J Med. 2007 Oct 4;357(14):1450-1. doi: 10.1056/NEJMc070359.

An addition to treatment options for avian influenza A H5N1?

Lancet Infect Dis. 2015 Mar;15(3):251-3. doi: 10.1016/S1473-3099(15)70019-8. Epub 2015 Feb 5.

Human single-chain antibodies that neutralize homologous and heterologous strains and clades of influenza A virus subtype H5N1.

Antivir Ther. 2009;14(2):221-30.

[Human monoclonal antibodies in preventive and therapeutic use against H5N1 virus].

Rev Med Suisse. 2007 Jun 13;3(115):1549.

[Influenza virus, human: two avenues for the new treatment].

Rev Med Suisse. 2009 Mar 11;5(194):605.

Successful treatment of avian influenza with convalescent plasma.

Hong Kong Med J. 2006 Dec;12(6):489.

引用本文的文献

Convalescent plasma therapy as a conventional trick for treating COVID-19: a systematic review and meta-analysis study.

New Microbes New Infect. 2021 Jul;42:100901. doi: 10.1016/j.nmni.2021.100901. Epub 2021 May 18.

Early experience with convalescent plasma as immunotherapy for COVID-19 in China: Knowns and unknowns.

Vox Sang. 2020 Aug;115(6):507-514. doi: 10.1111/vox.12968.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Blood products for Spanish influenza: a future H5N1 treatment?

作者信息

Logtenberg Susan J, Bilo Henk J

出版信息

Ann Intern Med. 2007 May 1;146(9):686-7; author reply 687. doi: 10.7326/0003-4819-146-9-200705010-00020.

DOI:10.7326/0003-4819-146-9-200705010-00020

PMID:17470841

Abstract

摘要

相似文献

Blood products for Spanish influenza: a future H5N1 treatment?

Ann Intern Med. 2007 May 1;146(9):686-7; author reply 687. doi: 10.7326/0003-4819-146-9-200705010-00020.

Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?

Ann Intern Med. 2006 Oct 17;145(8):599-609. doi: 10.7326/0003-4819-145-8-200610170-00139. Epub 2006 Aug 29.

Avian influenza: exploring all the avenues.

Ann Intern Med. 2006 Oct 17;145(8):631-2. doi: 10.7326/0003-4819-145-8-200610170-00140. Epub 2006 Aug 29.

Immunology. Flu antibodies stir new hope for treatment, vaccine.

Science. 2009 Feb 27;323(5918):1160. doi: 10.1126/science.323.5918.1160.

Treatment with convalescent plasma for influenza A (H5N1) infection.

N Engl J Med. 2007 Oct 4;357(14):1450-1. doi: 10.1056/NEJMc070359.

An addition to treatment options for avian influenza A H5N1?

Lancet Infect Dis. 2015 Mar;15(3):251-3. doi: 10.1016/S1473-3099(15)70019-8. Epub 2015 Feb 5.

Human single-chain antibodies that neutralize homologous and heterologous strains and clades of influenza A virus subtype H5N1.

Antivir Ther. 2009;14(2):221-30.

[Human monoclonal antibodies in preventive and therapeutic use against H5N1 virus].

Rev Med Suisse. 2007 Jun 13;3(115):1549.

[Influenza virus, human: two avenues for the new treatment].

Rev Med Suisse. 2009 Mar 11;5(194):605.

Successful treatment of avian influenza with convalescent plasma.

Hong Kong Med J. 2006 Dec;12(6):489.

引用本文的文献

Convalescent plasma therapy as a conventional trick for treating COVID-19: a systematic review and meta-analysis study.

New Microbes New Infect. 2021 Jul;42:100901. doi: 10.1016/j.nmni.2021.100901. Epub 2021 May 18.

Early experience with convalescent plasma as immunotherapy for COVID-19 in China: Knowns and unknowns.

Vox Sang. 2020 Aug;115(6):507-514. doi: 10.1111/vox.12968.